Education
About Us
Working with TipRanks
Follow Us
Cognetivity Neurosciences (CGNSF)
OTHER OTC:CGNSF
CGNSF Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.01
Previous CloseN/A
Volume100.00
Average Volume (3M)0.00
Market Cap
$650.18K
Enterprise ValueN/A
Total Cash (Recent Filing)$16.57K
Total Debt (Recent Filing)$2.74M
Price to Earnings (P/E)―
Beta0.23
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding89,588,610
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Cognetivity Neurosciences News
CGNSF FAQ
What was Cognetivity Neurosciences’s price range in the past 12 months?
Cognetivity Neurosciences lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is Cognetivity Neurosciences’s market cap?
Cognetivity Neurosciences’s market cap is $650.18K.
When is Cognetivity Neurosciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Cognetivity Neurosciences’s earnings last quarter?
Currently, no data Available
Is Cognetivity Neurosciences overvalued?
According to Wall Street analysts Cognetivity Neurosciences’s price is currently Overvalued.
Does Cognetivity Neurosciences pay dividends?
Cognetivity Neurosciences does not currently pay dividends.
What is Cognetivity Neurosciences’s EPS estimate?
Cognetivity Neurosciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cognetivity Neurosciences have?
Cognetivity Neurosciences has 89,588,610 shares outstanding.
What happened to Cognetivity Neurosciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Cognetivity Neurosciences?
Currently, no hedge funds are holding shares in CGNSF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Cognetivity Neurosciences
Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia; and offers OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Technical Analysis
Diagnos
―
Certive Solutions
―
EGF Theramed Health
―
Newtopia
―
PanGenomic Health, Inc. Class A
―